Cambridge Health Alliance has launched a clinical trial – the first in its history – to see if an inexpensive drug used safely for decades can prevent people with mild or moderate cases of Covid-19 from becoming more seriously ill.
As an independent publication, we rely on contributions from readers like you to fund our journalism.
Sign up to our free newsletter to get the latest news delivered straight to your inbox.
Thank you for registering!
News | Features | Commentary | Calendar
Cambridge Health Alliance has launched a clinical trial – the first in its history – to see if an inexpensive drug used safely for decades can prevent people with mild or moderate cases of Covid-19 from becoming more seriously ill.
